References
Asawakarn T, Cladera J, & O’Shea P (2001). Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells. J Biol Chem 276: 38457-38463.
Aykan DA, & Seyithanoglu M (2019). The effects of administration of vitamin D, infliximab, and leflunomide on testosterone concentrations in rats under atorvastatin therapy. Eurasian J Med 51: 224-227.
Bjorkhem-Bergman L, Lindh JD, & Bergman P (2011). What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br J Clin Pharmacol 72: 164-165.
Cladera J, & O’Shea P (1998). Intramembrane molecular dipoles affect the membrane insertion and folding of a model amphiphilic peptide. Biophys J 74: 2434-2442.
Clarke RJ (2015). Dipole-potential-mediated effects on ion pump kinetics. Biophys J 109: 1513-1520.
Clarke RJ, & Kane DJ (1997). Optical detection of membrane dipole potential: avoidance of fluidity and dye-induced effects. Biochimica et biophysica acta 1323: 223-239.
Corsini A, Maggi FM, & Catapano AL (1995). Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res 31: 9-27.
Crismaru I, Pantea Stoian A, Bratu OG, Gaman MA, Stanescu AMA, Bacalbasa N, et al. (2020). Low-density lipoprotein cholesterol lowering treatment: the current approach. Lipids Health Dis 19: 85.
Dawaliby R, Trubbia C, Delporte C, Noyon C, Ruysschaert JM, Van Antwerpen P, et al. (2016). Phosphatidylethanolamine is a key regulator of membrane fluidity in eukaryotic cells. J Biol Chem 291: 3658-3667.
Derossi D, Joliot AH, Chassaing G, & Prochiantz A (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269: 10444-10450.
Dobson PD, & Kell DB (2008). Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 7: 205-220.
Endo A, & Kuroda M (1976). Citrinin, an inhibitor of cholesterol synthesis. J Antibiot (Tokyo) 29: 841-843.
Endo A, Tsujita Y, Kuroda M, & Tanzawa K (1977). Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur J Biochem 77: 31-36.
Erazo-Oliveras A, Muthukrishnan N, Baker R, Wang TY, & Pellois JP (2012). Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals (Basel) 5: 1177-1209.
Fievet C, & Staels B (2009). Combination therapy of statins and fibrates in the management of cardiovascular risk. Curr Opin Lipidol 20: 505-511.
Flewelling RF, & Hubbell WL (1986). The membrane dipole potential in a total membrane potential model. Applications to hydrophobic ion interactions with membranes. Biophys J 49: 541-552.
Fominaya J, Bravo J, & Rebollo A (2015). Strategies to stabilize cell penetrating peptides for in vivo applications. Ther Deliv 6:1171-1194.
Futaki S (2006). Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms. Biopolymers 84: 241-249.
Göbel A, Breining D, Rauner M, Hofbauer LC, & Rachner TD (2019). Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells. Cell Death Dis 10: 91.
Gross E, Bedlack RS, Jr., & Loew LM (1994). Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. Biophys J 67: 208-216.
Guidotti G, Brambilla L, & Rossi D (2017). Cell-penetrating peptides: from basic research to clinics. Trends Pharmacol Sci 38:406-424.
Haldar S, Kanaparthi RK, Samanta A, & Chattopadhyay A (2012). Differential effect of cholesterol and its biosynthetic precursors on membrane dipole potential. Biophys J 102: 1561-1569.
Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, & Tsien RY (2004). Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 101: 17867-17872.
Joliot A, Pernelle C, Deagostini-Bazin H, & Prochiantz A (1991). Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci U S A 88: 1864-1868.
Jones P, Kafonek S, Laurora I, & Hunninghake D (1998). Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol 81: 582-587.
Kalliokoski A, & Niemi M (2009). Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 158: 693-705.
Kimbung S, Lettiero B, Feldt M, Bosch A, & Borgquist S (2016). High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer. Oncotarget 7: 59640-59651.
Kovács T, Batta G, Hajdu T, Szabó A, Váradi T, Zákány F, et al.(2016). The dipole potential modifies the clustering and ligand binding affinity of ErbB proteins and their signaling efficiency. Sci Rep 6: 35850.
Kovács T, Batta G, Zákány F, Szöllősi J, & Nagy P (2017). The dipole potential correlates with lipid raft markers in the plasma membrane of living cells. J Lipid Res 58: 1681-1691.
Kuhry JG, Fonteneau P, Duportail G, Maechling C, & Laustriat G (1983). TMA-DPH: a suitable fluorescence polarization probe for specific plasma membrane fluidity studies in intact living cells. Cell biophysics 5: 129-140.
Lonn P, Kacsinta AD, Cui XS, Hamil AS, Kaulich M, Gogoi K, et al.(2016). Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics. Sci Rep 6: 32301.
Luo P, Wang L, Zhu H, Du S, Wang G, & Ding S (2016). Impact of atorvastatin combined with ezetimibe for the treatment of carotid atherosclerosis in patients with coronary heart disease. Acta Cardiol Sin 32: 578-585.
Najjar K, Erazo-Oliveras A, Brock DJ, Wang TY, & Pellois JP (2017). An l- to d-Amino Acid Conversion in an Endosomolytic Analog of the Cell-penetrating Peptide TAT Influences Proteolytic Stability, Endocytic Uptake, and Endosomal Escape. J Biol Chem 292: 847-861.
Nakase I, Kogure K, Harashima H, & Futaki S (2011). Application of a fusiogenic peptide GALA for intracellular delivery. Methods Mol Biol 683: 525-533.
O’Shea P (2003). Intermolecular interactions with/within cell membranes and the trinity of membrane potentials: kinetics and imaging. Biochem Soc Trans 31: 990-996.
Parasassi T, De Stasio G, Ravagnan G, Rusch RM, & Gratton E (1991). Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys J 60: 179-189.
Pearlstein RA, Dickson CJ, & Hornak V (2017). Contributions of the membrane dipole potential to the function of voltage-gated cation channels and modulation by small molecule potentiators. Biochimica et biophysica acta 1859: 177-194.
Poon GM, & Gariepy J (2007). Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem Soc Trans 35: 788-793.
Qian Z, Dougherty PG, & Pei D (2015). Monitoring the cytosolic entry of cell-penetrating peptides using a pH-sensitive fluorophore. Chemical Communications 51: 2162-2165.
Qian Z, Martyna A, Hard RL, Wang J, Appiah-Kubi G, Coss C, et al.(2016). Discovery and mechanism of highly efficient cyclic cell-penetrating peptides. Biochemistry 55: 2601-2612.
Repke H, & Bienert M (1987). Mast cell activation–a receptor-independent mode of substance P action? FEBS Lett 221:236-240.
Rothbard JB, Jessop TC, & Wender PA (2005). Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv Drug Deliv Rev 57: 495-504.
Sarkar P, Chakraborty H, & Chattopadhyay A (2017). Differential membrane dipolar orientation induced by acute and chronic cholesterol depletion. Sci Rep 7: 4484.
Schachter M (2005). Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 19:117-125.
Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JL, Seman LJ, et al. (2004). Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects. Am J Cardiol 93: 31-39.
Sidaway JE, Davidson RG, McTaggart F, Orton TC, Scott RC, Smith GJ, et al. (2004). Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells. J Am Soc Nephrol 15: 2258-2265.
Simon SA, McIntosh TJ, Magid AD, & Needham D (1992). Modulation of the interbilayer hydration pressure by the addition of dipoles at the hydrocarbon/water interface. Biophys J 61: 786-799.
Starke-Peterkovic T, Turner N, Vitha MF, Waller MP, Hibbs DE, & Clarke RJ (2006). Cholesterol effect on the dipole potential of lipid membranes. Biophys J 90: 4060-4070.
Thoren PE, Persson D, Esbjorner EK, Goksor M, Lincoln P, & Norden B (2004). Membrane binding and translocation of cell-penetrating peptides. Biochemistry 43: 3471-3489.
van den Brand D, Veelken C, Massuger L, & Brock R (2018). Penetration in 3D tumor spheroids and explants: Adding a further dimension to the structure-activity relationship of cell-penetrating peptides. Biochim Biophys Acta Biomembr 1860: 1342-1349.
Via MA, Del Popolo MG, & Wilke N (2018). Negative dipole potentials and carboxylic polar head groups foster the insertion of cell-penetrating peptides into lipid monolayers. Langmuir 34: 3102-3111.
Via MA, Klug J, Wilke N, Mayorga LS, & Del Popolo MG (2018). The interfacial electrostatic potential modulates the insertion of cell-penetrating peptides into lipid bilayers. Phys Chem Chem Phys 20: 5180-5189.
Wallbrecher R, Depre L, Verdurmen WP, Bovee-Geurts PH, van Duinkerken RH, Zekveld MJ, et al. (2014). Exploration of the design principles of a cell-penetrating bicylic peptide scaffold. Bioconjug Chem 25: 955-964.
Wang F, Wang Y, Zhang X, Zhang W, Guo S, & Jin F (2014). Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. J Control Release 174: 126-136.
Wang L (2012). Measurements and implications of the membrane dipole potential. Annual review of biochemistry 81: 615-635.
Wu X, Whitfield LR, & Stewart BH (2000). Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharm Res 17:209-215.
Yilmaz A, Reiss C, Weng A, Cicha I, Stumpf C, Steinkasserer A, et al. (2006). Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol 79:529-538.
Zákány F, Kovács T, Panyi G, & Varga Z (2020). Direct and indirect cholesterol effects on membrane proteins with special focus on potassium channels. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158706.
Zhang J, Li Q, Wu Y, Wang D, Xu L, Zhang Y, et al. (2019). Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer. Cell Commun Signal 17: 15.
Ziegler A (2008). Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans. Adv Drug Deliv Rev 60: 580-597.